🇺🇸 MRK — Merck & Co., Inc.

Healthcare Compra
← Volver

Precio actual

150,33 USD

Máx. histórico

156,92

10 días

Caída desde máximo

-4,20%

Rango 52 semanas

77,58 – 156,92

Variación hoy

-1,32%

Cierre anterior

152,34

Rango de hoy

150,09 – 152,22

Volumen hoy

4.298.143

Información
Nombre completo
Merck & Co., Inc.
Divisa
USD
Mercado
NYSE
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
73.000
PER ⓘ
122,22 (puede no estar actualizado)
Dividend yield
2,23% (puede no estar actualizado)
Precio objetivo analistas
148,73 USD (puede no estar actualizado)
Primera cotización
02/01/1962
Precio actualizado
hace 2 días
Sobre la empresa

Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.

Dividendos repartidos Total últimos 12 meses: 3,3600 USD · Yield: 2,24%
Fecha de pago Importe por participación
04/09/1996 0,1908 USD
06/06/1996 0,1622 USD
06/03/1996 0,1622 USD
06/12/1995 0,1622 USD
05/09/1995 0,1622 USD
02/06/1995 0,1431 USD
03/03/1995 0,1431 USD
02/12/1994 0,1431 USD
02/09/1994 0,1431 USD
02/06/1994 0,1336 USD
02/03/1994 0,1336 USD
02/12/1993 0,1336 USD
02/09/1993 0,1336 USD
02/06/1993 0,1193 USD
02/03/1993 0,1193 USD
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
29/03/1978 1,29 1,30 1,29 1,29 +0,00% 1,28% 1.644.941
28/03/1978 1,28 1,30 1,28 1,29 +1,29% 1,56% 2.659.824
27/03/1978 1,29 1,29 1,26 1,28 -2,77% 2,32% 4.549.997
23/03/1978 1,34 1,34 1,30 1,31 -2,47% 2,72% 3.067.286
22/03/1978 1,36 1,36 1,34 1,35 -1,45% 1,46% 6.096.845
21/03/1978 1,40 1,40 1,37 1,37 -2,83% 2,37% 2.142.950
20/03/1978 1,39 1,41 1,39 1,40 +2,17% 1,19% 2.629.642
17/03/1978 1,36 1,38 1,35 1,38 +1,22% 2,44% 1.750.579
16/03/1978 1,36 1,36 1,35 1,36 -0,48% 0,73% 3.320.064
15/03/1978 1,39 1,40 1,37 1,37 -1,67% 2,39% 2.607.005
14/03/1978 1,39 1,40 1,38 1,39 -0,48% 0,95% 1.950.538
13/03/1978 1,41 1,42 1,39 1,39 -0,94% 2,12% 2.142.950
10/03/1978 1,39 1,41 1,39 1,41 +1,43% 1,43% 2.486.275
09/03/1978 1,38 1,40 1,38 1,39 +1,20% 1,69% 2.203.315
08/03/1978 1,37 1,38 1,36 1,37 +0,49% 1,22% 1.282.752
07/03/1978 1,36 1,38 1,36 1,37 +0,49% 1,22% 822.470
06/03/1978 1,37 1,37 1,36 1,36 -0,97% 1,21% 1.407.254
03/03/1978 1,38 1,38 1,36 1,37 -0,48% 1,44% 1.656.259
02/03/1978 1,39 1,39 1,37 1,38 -1,42% 1,67% 1.859.990
01/03/1978 1,39 1,41 1,39 1,40 +0,24% 1,43% 1.520.438
28/02/1978 1,40 1,40 1,38 1,39 -1,17% 1,42% 913.018
27/02/1978 1,41 1,43 1,41 1,41 -0,23% 1,41% 1.033.747
24/02/1978 1,41 1,42 1,41 1,41 +0,94% 0,94% 1.071.475
23/02/1978 1,40 1,40 1,39 1,40 -0,23% 0,71% 1.501.574
22/02/1978 1,42 1,42 1,40 1,40 -0,93% 1,17% 2.108.995
21/02/1978 1,42 1,42 1,40 1,42 +0,00% 0,93% 1.712.851
17/02/1978 1,44 1,45 1,41 1,42 -1,38% 2,54% 1.592.122
16/02/1978 1,45 1,45 1,43 1,44 -0,92% 1,60% 4.700.909
15/02/1978 1,47 1,48 1,45 1,45 -1,57% 1,80% 2.248.589
14/02/1978 1,48 1,49 1,47 1,47 -0,67% 0,89% 1.048.838